Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.
Författare
Summary, in English
Tyrosine kinase inhibitors (TKIs) used in the treatment of chronic myeloid leukaemia have been reported to induce immunomodulatory effects. We aimed to assess peripheral blood (PB) and bone marrow (BM) lymphocyte status at the diagnosis and during different TKI therapies and correlate it with treatment responses.
Publiceringsår
2016-01-08
Språk
Engelska
Sidor
1041-1050
Publikation/Tidskrift/Serie
Journal of Cancer Research and Clinical Oncology
Volym
142
Issue
5
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
Springer
Ämne
- Hematology
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 1432-1335